Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (51-60 of 244) with videos related to

Pageof 25
Sort By:
Bipolar Disorders|January 31, 2013
Gene expression alterations in bipolar disorder postmortem brainsHaiming Chen, Nulang Wang, Xin Zhao, et al.
Neuroscience Research|April 10, 2007
PC12 cell model of inducible expression of mutant DISC1: new evidence for a dominant-negative mechanism of abnormal neuronal differentiationMikhail V Pletnikov, Yanqun Xu, Mikhail V Ovanesov, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 3, 2004
Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degenerationChristine M Liszewski, Elizabeth O'Hearn, Iracema Leroi, et al.
Journal of Huntington'S Disease|March 12, 2019
Cysteamine Protects Neurons from Mutant Huntingtin ToxicityNicolas Arbez, Elaine Roby, Sergey Akimov, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3Gina M Zainelli, Nichole L Dudek, Christopher A Ross, et al.
Neuron|October 4, 2006
Neurobiology of schizophreniaChristopher A Ross, Russell L Margolis, Sarah A J Reading, et al.
The European Journal of Neuroscience|January 17, 2004
The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtinHélène Rangone, Ghislaine Poizat, Juan Troncoso, et al.
Plos Currents|May 20, 2011
Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington DiseaseElizabeth Aylward, James Mills, Dawei Liu, et al.
Molecular Neurobiology|November 21, 2025
Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's DiseaseJing Jin, Randal Hand, May Meltzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2013
Elevated arteriolar cerebral blood volume in prodromal Huntington's diseaseJun Hua, Paul G Unschuld, Russell L Margolis, et al.
Pageof 25

Showing results (51-60 of 244) with videos related to

Sort By:
Pageof 25
Bipolar Disorders|January 31, 2013
Gene expression alterations in bipolar disorder postmortem brainsHaiming Chen, Nulang Wang, Xin Zhao, et al.
Neuroscience Research|April 10, 2007
PC12 cell model of inducible expression of mutant DISC1: new evidence for a dominant-negative mechanism of abnormal neuronal differentiationMikhail V Pletnikov, Yanqun Xu, Mikhail V Ovanesov, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 3, 2004
Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degenerationChristine M Liszewski, Elizabeth O'Hearn, Iracema Leroi, et al.
Journal of Huntington'S Disease|March 12, 2019
Cysteamine Protects Neurons from Mutant Huntingtin ToxicityNicolas Arbez, Elaine Roby, Sergey Akimov, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3Gina M Zainelli, Nichole L Dudek, Christopher A Ross, et al.
Neuron|October 4, 2006
Neurobiology of schizophreniaChristopher A Ross, Russell L Margolis, Sarah A J Reading, et al.
The European Journal of Neuroscience|January 17, 2004
The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtinHélène Rangone, Ghislaine Poizat, Juan Troncoso, et al.
Plos Currents|May 20, 2011
Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington DiseaseElizabeth Aylward, James Mills, Dawei Liu, et al.
Molecular Neurobiology|November 21, 2025
Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's DiseaseJing Jin, Randal Hand, May Meltzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2013
Elevated arteriolar cerebral blood volume in prodromal Huntington's diseaseJun Hua, Paul G Unschuld, Russell L Margolis, et al.
Pageof 25